This article describes why Leronlimab, despite great results and minimal side effects, is stuck in the drawn out FDA process and why few medical professionals are aware of it. This article also demonstrates why CYDY NEEDS a big pharm partner to get the drug out to those that need it. The system is corrupt and often results in the wrong medications or treatments being recommended, but we know that in the case of leronlimab, it has a lot of benefits.

There’s a Dr who is mentioned on this board as always supporting the wrong HIV treatment or one that has heavy side effects. I cannot recall his name, but money is why’s he’s not on leronlimab’s side. They are called “pharm bros” and are detrimental to the EBM system.

I refer to EBM often when recommending treatments to patients or when I’m deciding on how to treat a specific diagnosis. I’ve known about the influence that big pharma has but it’s hard NOT to refer to journal studies or other large BP studies because I cannot draw conclusions on my own for obvious reasons (small patient number, close follow up, etc). I admit that it’s a broken system, but what leronlimab needs is the influence of big pharma to get going.

https://medium.com/@drjasonfung/the-corruptio...f2812b8704